Treadwell Therapeutics Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 14

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 7

Treadwell Therapeutics General Information

Description

Developer of a biotechnology platform designed to exploit cancer cell vulnerabilities and provide small molecules to address unmet needs in patients. The company's platform helps discover and develop a multifunctional engine that requires highly experienced experts in both drug discovery and early to late-stage clinical development, enabling patients to recover faster from various diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Unit 506, 5/F New World Tower 1
  • 18 Queens Road Central
  • Hong Kong
  • Hong Kong
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • Unit 506, 5/F New World Tower 1
  • 18 Queens Road Central
  • Hong Kong
  • Hong Kong

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Treadwell Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Secondary Transaction - Private Completed Clinical Trials - Phase 1
2. Early Stage VC (Series B) 18-Nov-2021 Completed Clinical Trials - Phase 1
1. Seed Round 13-Jan-2020 $27M $27M Completed Clinical Trials - Phase 1
To view Treadwell Therapeutics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Treadwell Therapeutics Patents

Treadwell Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025088530-A1 T cell receptors and methods of use thereof Inactive 24-Oct-2023

Treadwell Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Treadwell Therapeutics Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
3W Partners Capital PE/Buyout Minority
China Fortune Ocean Fund Venture Capital Minority
Fuhai Assets Asset Manager Minority
Prosperous Alliance Asset Manager Minority
Sino Biopharmaceutical Corporation Minority
You’re viewing 5 of 7 investors. Get the full list »

Treadwell Therapeutics Acquisitions (1)

Treadwell Therapeutics’s most recent deal was a Merger/Acquisition with TCRyption. The deal was made on 15-Oct-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
TCRyption 15-Oct-2021 Merger/Acquisition Biotechnology
To view Treadwell Therapeutics’s complete acquisitions history, request access »

Treadwell Therapeutics FAQs

  • When was Treadwell Therapeutics founded?

    Treadwell Therapeutics was founded in 2018.

  • Where is Treadwell Therapeutics headquartered?

    Treadwell Therapeutics is headquartered in Hong Kong, Hong Kong.

  • What is the size of Treadwell Therapeutics?

    Treadwell Therapeutics has 14 total employees.

  • What industry is Treadwell Therapeutics in?

    Treadwell Therapeutics’s primary industry is Drug Discovery.

  • Is Treadwell Therapeutics a private or public company?

    Treadwell Therapeutics is a Private company.

  • What is Treadwell Therapeutics’s current revenue?

    The current revenue for Treadwell Therapeutics is .

  • How much funding has Treadwell Therapeutics raised over time?

    Treadwell Therapeutics has raised $118M.

  • Who are Treadwell Therapeutics’s investors?

    3W Partners Capital, China Fortune Ocean Fund, Fuhai Assets, Prosperous Alliance, and Sino Biopharmaceutical are 5 of 7 investors who have invested in Treadwell Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process